Activation of adenovirus type 2 early region 4 ORF4 cytoplasmic death function by direct binding to Src kinase domain

Claudia Champagne1, Marie-Claude Landry, Marie-Claude Gingras

  • 1Centre de Recherche en Cancérologie de l'Université Laval, L'Hôtel-Dieu de Québec, CHUQ, Québec G1R 2J6, Canada.

Insights

Adenovirus E4orf4 protein interacts with Src kinase, disrupting cell signaling and triggering cell death. This interaction is crucial for E4orf4-induced tumor cell killing, involving both Src and PP2A enzymes.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Virology

Background:

  • Adenovirus type 2 early region 4 ORF4 (E4orf4) induces a cell death pathway.
  • This pathway is regulated by Src family kinases and is resistant to ZVAD and Bcl2 inhibitors.
  • The mechanism by which E4orf4 deregulates Src signaling was previously unknown.

Purpose of the Study:

  • To elucidate the molecular mechanism of E4orf4-induced cell death.
  • To investigate the interaction between E4orf4 and Src family kinases.
  • To determine the roles of Src and protein phosphatase 2A (PP2A) in E4orf4-mediated cell death.

Main Methods:

  • Co-immunoprecipitation assays to detect protein interactions.
  • Site-directed mutagenesis of E4orf4 to study binding domains.
  • Cellular assays to assess signaling pathway activation and cell morphology.
  • Analysis of cell death induction in various cell types.

Main Results:

  • E4orf4 physically interacts with the kinase domain of Src.
  • This interaction requires E4orf4's arginine-rich motif and leads to Src signaling deregulation.
  • E4orf4 also binds to PP2A-Balpha, contributing to a distinct cell death activity.
  • Src binding is critical for Jun kinase pathway activation and cell blebbing, while PP2A binding is important for another death activity.

Conclusions:

  • E4orf4 binding to Src kinase deregulates Src signaling, inducing a cytoplasmic death pathway.
  • Both Src and PP2A are critical targets of E4orf4, cooperating in tumor cell killing.
  • The relative contributions of Src and PP2A may vary depending on the cellular context.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...